Progress in Advancing Basic Cancer Research
The Division of Cancer Biology (DCB) supports important fundamental discoveries across the entire spectrum of cancer biology, from structural insights to mechanisms of metastasis, which lay the foundation for advances in cancer prevention and treatment. The division also fosters emerging scientific areas and a cancer research workforce to sustain continual opportunities and progress in basic cancer research.
DCB identifies, enables, and promotes impactful basic cancer biology research by supporting a vibrant community towards the advancement of fundamental knowledge and insights that, ultimately, provide a foundation for better health and well-being for patients and their advocates.
Progress in Advancing Basic Cancer Research
-
Research Advances in Cancer BiologyExamples of discoveries in cancer biology from DCB funded research projects in the past year.
-
Timeline of Division of Cancer Biology MilestonesA list of DCB activities over time that contributed to progress in basic cancer research.
-
Investigators from the Division of Cancer BiologyCancer researchers supported by DCB are advancing our fundamental understanding of cancer.
Progress in Advancing Basic Cancer Research
-
Fundamental Research Paved the Way for the Development of Vorasidenib, a New Promising Clinical TreaCancer biology research was involved in the development of Vorasidenib, a new clinical treatment for IDH-mutant brain tumors.
-
Cancer Biology Research is Advancing Progress Towards NCP GoalsFundamental research and outreach activities supported by DCB are helping to achieve the goals of the National Cancer Plan (NCP).
-
FY24 Division of Cancer Biology Progress in Advancing Basic Cancer ResearchLearn how NCI’s Division of Cancer Biology enables cancer biology research, supports basic cancer researchers, and fosters emerging scientific areas.